GAP provides the full, or bespoke, services for signal detection. Currently, signal detection is made mandatory in Europe and the U.S. to review and generate the potential signals that comes across in the discovery of the adverse event relationship. We understand the importance of risk-benefit ratio, signal triage algorithm, good Pharmacovigilance practice which follows the compliance guidelines. Our physicians bring information from the various sources, including the organization data (safety, registries, clinical, and sales) and outside data sources (FDA AERS, WHO Vigibase). GAP contented with:
Contact us for more information.